SonarMed is a privately held medical device company based in Carmel, Indiana that develops airway-monitoring products for pediatric and adult critical care. Its core product, the AirWave System, is 510(k) cleared for adult and pediatric patients, including neonates. The company’s pediatric sensors incorporate upgraded piezoelectric monitoring technology to address moisture and secretion-related clogging that affects capnography-based sensors. Proceeds from its Series C financing are being used to support a controlled market roll-out, the launch of pediatric products, and continued collection of outcomes data from user case studies. SonarMed also plans to add two new pediatric products to its pipeline within the year. Management cites a $350 million NICU and pediatric market opportunity as part of an overall $1 billion market.

Total raised

$3M

Funding rounds

1

Latest round

Series C

Latest activity

Oct 2017